In largest ever settlement,Ranbaxy to pay $ 500 mn

Generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India.

The US subsidiary of Ranbaxy Monday agreed to pay

$ 500 million after pleading guilty to felony charges related to the manufacture and distribution of adulterated drugs at two units in India.

The US Justice Department said in a statement: In the largest drug safety settlement to date with a generic drug manufacturer,Ranbaxy USA,a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories,pleaded guilty today to felony charges relating to manufacture and distribution of certain adulterated drugs made at two of Ranbaxys manufacturing facilities in India.

Ranbaxy also agreed to pay a criminal fine and forfeiture totalling $ 150 million and to settle civil claims under the False Claims Act and related state laws for $ 350 million, the statement added.

Nizamuddin went to the US in December 2015 for a Master’s course in Computer Science, which he completed from Florida Institute of Technology in 2017. He completed his B.Tech in ECE from Jayaprakash Narayan College of Engineering, Mahbubnagar.

‘Complained of racial discrimination’: Family of Indian techie shot dead by police in US

India55 min ago

31-year-old Mohammed Nizamuddin was allegedly shot dead by police in Santa Clara, California on September 3. His family was informed 15 days later and are struggling to understand what happened. Nizamuddin had complained about racial discrimination and harassment before quitting his job. His father has requested assistance in bringing his son's body back home.

View all shorts

Live Blog